Quick Answer
Entera Bio Ltd. reported Net Income of -$11.44 million for fiscal year 2025.
Entera Bio Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$11.44M | -19.9% |
| 2024 | -$9.54M | -7.3% |
| 2023 | -$8.89M | +32.0% |
| 2022 | -$13.07M | -7.3% |
| 2021 | -$12.19M | -8.7% |
| 2020 | -$11.22M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.20M | -5.9% | -20.5% |
| June 30, 2025 | -$2.66M | -23.8% | -3.5% |
| March 31, 2025 | -$2.57M | -27.3% | +15.0% |
| September 30, 2024 | -$3.02M | -27.0% | -40.8% |
| June 30, 2024 | -$2.15M | +7.7% | -6.3% |
| March 31, 2024 | -$2.02M | +7.9% | +15.2% |
| September 30, 2023 | -$2.38M | +22.4% | -2.3% |
| June 30, 2023 | -$2.33M | +27.0% | -6.2% |
- Entera Bio Ltd. showed a decrease of -19.9% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Entera Bio Ltd.’s net income has declined by 2.0% (from -$11.22 million to -$11.44 million).
- The most recent figure is from Entera Bio Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: